YU2901A - Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija - Google Patents
Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacijaInfo
- Publication number
- YU2901A YU2901A YU2901A YU2901A YU2901A YU 2901 A YU2901 A YU 2901A YU 2901 A YU2901 A YU 2901A YU 2901 A YU2901 A YU 2901A YU 2901 A YU2901 A YU 2901A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compounds
- compositions
- elongation
- methods
- neuronal growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Ovaj pronalazak se odnosi na jedinjenja koja inhibiraju peptidil-prolil izomere (rotomaze) enzimsku aktivnost FK-506 vezujući protein (FKBP) i kompozicije koje sadrže ova jedinjenja kako je dato u opisu. Farmaceutske kompozicije koje sadrže takva jedinjenja pomažu pri stimulaciji rasta neuita u nervnim ćelijama i dovode do regeneracije nerva. Metodi tretmana nervnih ćelija takvim kompozicijama koriste da podpomognu obnavljanje oštećenja na neuronima izazvanih bolestima ili fizičkom traumom.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9329998P | 1998-07-17 | 1998-07-17 | |
US13288499P | 1999-05-06 | 1999-05-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU2901A true YU2901A (sh) | 2004-05-12 |
Family
ID=26787372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU2901A YU2901A (sh) | 1998-07-17 | 1999-07-15 | Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija |
Country Status (35)
Country | Link |
---|---|
US (1) | US6630472B1 (sh) |
EP (1) | EP1098897B1 (sh) |
JP (1) | JP2002520413A (sh) |
KR (1) | KR20010071920A (sh) |
CN (1) | CN1318067A (sh) |
AP (1) | AP2001002052A0 (sh) |
AT (1) | ATE268772T1 (sh) |
AU (1) | AU756912B2 (sh) |
BG (1) | BG105268A (sh) |
BR (1) | BR9912423A (sh) |
CA (1) | CA2337377A1 (sh) |
DE (1) | DE69917907T2 (sh) |
DK (1) | DK1098897T3 (sh) |
EA (1) | EA200100149A1 (sh) |
EE (1) | EE200100032A (sh) |
ES (1) | ES2226409T3 (sh) |
GE (1) | GEP20043368B (sh) |
HR (1) | HRP20010118A2 (sh) |
HU (1) | HUP0200637A3 (sh) |
ID (1) | ID27428A (sh) |
IL (1) | IL140676A0 (sh) |
IS (1) | IS5805A (sh) |
LT (1) | LT4850B (sh) |
LV (1) | LV12665B (sh) |
NO (1) | NO20010191L (sh) |
NZ (1) | NZ509211A (sh) |
OA (1) | OA11581A (sh) |
PL (1) | PL345598A1 (sh) |
PT (1) | PT1098897E (sh) |
SI (1) | SI20638A (sh) |
SK (1) | SK462001A3 (sh) |
TR (1) | TR200100122T2 (sh) |
WO (1) | WO2000004020A1 (sh) |
YU (1) | YU2901A (sh) |
ZA (1) | ZA200100320B (sh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6818643B1 (en) * | 1999-12-08 | 2004-11-16 | Bristol-Myers Squibb Company | Neurotrophic bicyclic diamides |
CA2446795A1 (en) * | 2001-05-10 | 2002-11-14 | Agouron Pharmaceuticals, Inc. | Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands |
WO2015110271A1 (en) * | 2014-01-24 | 2015-07-30 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders |
EP2899192A1 (en) * | 2014-01-24 | 2015-07-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
US5109112A (en) | 1989-01-19 | 1992-04-28 | Merck & Co., Inc. | FK-506 cytosolic binding protein |
US5196352A (en) | 1989-01-19 | 1993-03-23 | Merck & Co., Inc. | New FK-506 cytosolic binding protein |
US5192773A (en) | 1990-07-02 | 1993-03-09 | Vertex Pharmaceuticals, Inc. | Immunosuppressive compounds |
US5187166A (en) * | 1990-07-31 | 1993-02-16 | Nisshin Flour Milling Co., Ltd. | Azabicyclo derivatives and their use as antiemetics |
US5256656A (en) * | 1990-07-31 | 1993-10-26 | Nisshin Flour Milling Co., Ltd. | Azabicyclo derivatives |
CA2068062A1 (en) | 1991-05-07 | 1992-11-08 | Stephen A. Parent | Yeast mutants |
US5362629A (en) | 1991-08-05 | 1994-11-08 | President And Fellows Of Harvard College | Detection of immunosuppressants |
US5344831A (en) * | 1992-01-31 | 1994-09-06 | Nisshin Flour Milling Co., Ltd. | Diazabicyclo derivatives |
DE4219973A1 (de) | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
US5318895A (en) | 1992-10-05 | 1994-06-07 | Merck & Co., Inc. | Aspergillus niger mutants |
US5798355A (en) | 1995-06-07 | 1998-08-25 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity |
JP3235913B2 (ja) * | 1993-07-30 | 2001-12-04 | エーザイ株式会社 | アミノ安息香酸誘導体 |
US5612350A (en) | 1993-11-30 | 1997-03-18 | Abbott Laboratories | Macrocyclic immunomodulators with novel cyclohexyl ring replacements |
DE4341402A1 (de) | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
US5457182A (en) | 1994-02-15 | 1995-10-10 | Merck & Co., Inc. | FK-506 cytosolic binding protein, FKBP12.6 |
US5622866A (en) | 1994-06-23 | 1997-04-22 | Merck & Co., Inc. | Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces |
US5696135A (en) | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
US5614547A (en) | 1995-06-07 | 1997-03-25 | Guilford Pharmaceuticals Inc. | Small molecule inhibitors of rotamase enzyme |
US5859031A (en) * | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
US6037370A (en) | 1995-06-08 | 2000-03-14 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5801197A (en) * | 1995-10-31 | 1998-09-01 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
US5801187A (en) | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
US5786378A (en) | 1996-09-25 | 1998-07-28 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters |
US5811434A (en) | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
US5840736A (en) | 1996-11-13 | 1998-11-24 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5780484A (en) | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
PA8442401A1 (es) | 1996-12-09 | 2000-05-24 | Guilford Pharm Inc | Inhibidores polipropilos de ciclofilina |
US5935989A (en) | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
US5874449A (en) | 1996-12-31 | 1999-02-23 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of heterocyclic thioesters |
US5721256A (en) | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
ZA98825B (en) | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
US5846979A (en) | 1997-02-28 | 1998-12-08 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic esters, amides, thioesters, and ketones |
-
1999
- 1999-07-15 DK DK99934043T patent/DK1098897T3/da active
- 1999-07-15 SK SK46-2001A patent/SK462001A3/sk unknown
- 1999-07-15 BR BR9912423-8A patent/BR9912423A/pt not_active Application Discontinuation
- 1999-07-15 AP APAP/P/2001/002052A patent/AP2001002052A0/en unknown
- 1999-07-15 NZ NZ509211A patent/NZ509211A/xx unknown
- 1999-07-15 PT PT99934043T patent/PT1098897E/pt unknown
- 1999-07-15 EE EEP200100032A patent/EE200100032A/xx unknown
- 1999-07-15 GE GE4273A patent/GEP20043368B/en unknown
- 1999-07-15 EP EP99934043A patent/EP1098897B1/en not_active Expired - Lifetime
- 1999-07-15 DE DE69917907T patent/DE69917907T2/de not_active Expired - Fee Related
- 1999-07-15 ID IDW20010130A patent/ID27428A/id unknown
- 1999-07-15 IL IL14067699A patent/IL140676A0/xx unknown
- 1999-07-15 TR TR2001/00122T patent/TR200100122T2/xx unknown
- 1999-07-15 EA EA200100149A patent/EA200100149A1/ru unknown
- 1999-07-15 CA CA002337377A patent/CA2337377A1/en not_active Abandoned
- 1999-07-15 CN CN99810848A patent/CN1318067A/zh active Pending
- 1999-07-15 HU HU0200637A patent/HUP0200637A3/hu unknown
- 1999-07-15 AU AU49963/99A patent/AU756912B2/en not_active Ceased
- 1999-07-15 YU YU2901A patent/YU2901A/sh unknown
- 1999-07-15 PL PL99345598A patent/PL345598A1/xx not_active Application Discontinuation
- 1999-07-15 JP JP2000560126A patent/JP2002520413A/ja not_active Withdrawn
- 1999-07-15 KR KR1020017000654A patent/KR20010071920A/ko not_active Application Discontinuation
- 1999-07-15 OA OA1200100015A patent/OA11581A/en unknown
- 1999-07-15 WO PCT/US1999/015965 patent/WO2000004020A1/en not_active Application Discontinuation
- 1999-07-15 ES ES99934043T patent/ES2226409T3/es not_active Expired - Lifetime
- 1999-07-15 SI SI9920067A patent/SI20638A/sl not_active IP Right Cessation
- 1999-07-15 AT AT99934043T patent/ATE268772T1/de not_active IP Right Cessation
- 1999-07-16 US US09/356,240 patent/US6630472B1/en not_active Expired - Fee Related
-
2001
- 2001-01-11 ZA ZA200100320A patent/ZA200100320B/en unknown
- 2001-01-12 NO NO20010191A patent/NO20010191L/no not_active Application Discontinuation
- 2001-01-12 IS IS5805A patent/IS5805A/is unknown
- 2001-02-15 LT LT2001012A patent/LT4850B/lt not_active IP Right Cessation
- 2001-02-16 HR HR20010118A patent/HRP20010118A2/hr not_active Application Discontinuation
- 2001-02-16 BG BG105268A patent/BG105268A/xx unknown
- 2001-03-13 LV LV010023A patent/LV12665B/lv unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26464A1 (es) | " compuestos, composiciones y métodos para estimular el crecimiento y elongación de neuronas" | |
DE60029799D1 (de) | Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe | |
NZ310339A (en) | Compositions for stimulating neurite growth comprising a neurotrophic amount of a compound with affinity for FKBP12 and a neurotrophic agent | |
BR0315645A (pt) | Polipetìdeos de fusão de actrib e seus usos | |
EA199800393A1 (ru) | Композиции и способы их применение для лечения поражения костей | |
EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
PT1311285E (pt) | Composicao farmaceutica liquida contendo um derivado de eritropoietina | |
EA200600076A1 (ru) | Композиции и способы увеличения активности теломеразы | |
TW200510306A (en) | Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them | |
ES2163034T3 (es) | Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana. | |
AU2085201A (en) | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death | |
DE60026568D1 (de) | Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung | |
EA200800011A1 (ru) | Тиенопиримидиновые и тиенопиридиновые модуляторы киназы | |
WO2008006544A3 (de) | Verwendung von gelatine und einem vernetzungsmittel zur herstellung einer vernetzenden therapeutischen zusammensetzung | |
NZ505742A (en) | Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses | |
DE60019318D1 (de) | Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe | |
BR9906926A (pt) | Composições e métodos para tratamento de células tendo dna de minuto duplo | |
EP0859636A4 (en) | HYALURONIC ACID USED AS A DNA CARRIER FOR GENE THERAPY AND ANTI-SENSE DNA OF THE VASCULAR ENDOTHELIUM GROWTH FACTOR FOR THE TREATMENT OF ABNORMAL RETINA VASCULARIZATION | |
EA200500934A1 (ru) | Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний | |
WO2000018801A3 (en) | Ncam binding compounds | |
YU2901A (sh) | Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija | |
WO2001042784A3 (en) | Methods for screening compounds active on neurons | |
AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. | |
BRPI0409683A (pt) | 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos | |
WO1997014966B1 (en) | Method of activating a novel ligand regulatory pathway |